Rigel Announces Third Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Rigel Pharma (RIGL) Tops Q3 EPS by 4c
November 5, 2019 4:54 PM ESTRigel Pharma (NASDAQ: RIGL) reported Q3 EPS of ($0.07), $0.04 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $20.86 million versus the consensus estimate of $16.38 million.
"We continue to demonstrate progress in all of the key value drivers for Rigel," said... More
